APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nonerosive Reflux Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nonerosive Reflux Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174017780319 December 2025181 pages

Choose your research edition.

Industry ResearchNonerosive Reflux Disease Treatment Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Nonerosive Reflux Disease Treatment Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Nonerosive Reflux Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nonerosive Reflux Disease Treatment Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Nonerosive Reflux Disease Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Nonerosive Reflux Disease Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Nonerosive Reflux Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nonerosive Reflux Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nonerosive Reflux Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nonerosive Reflux Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nonerosive Reflux Disease Treatment include Takeda Pharmaceutical, Eisai, Johnson & Johnson, GlaxoSmithKline, AstraZeneca, SRS Pharmaceuticals, SFJ Pharmaceuticals Group, Ironwood Pharmaceuticals and Daewoong Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Nonerosive Reflux Disease Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nonerosive Reflux Disease Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nonerosive Reflux Disease Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Nonerosive Reflux Disease Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Nonerosive Reflux Disease Treatment Segment by Company

Takeda Pharmaceutical

Eisai

Johnson & Johnson

GlaxoSmithKline

AstraZeneca

SRS Pharmaceuticals

SFJ Pharmaceuticals Group

Ironwood Pharmaceuticals

Daewoong Pharmaceutical

Nonerosive Reflux Disease Treatment Segment by Type

H2 Receptor Antagonists

Antacids

Proton pump inhibitors

Others

Nonerosive Reflux Disease Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Nonerosive Reflux Disease Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nonerosive Reflux Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nonerosive Reflux Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nonerosive Reflux Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Nonerosive Reflux Disease Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nonerosive Reflux Disease Treatment industry.

Chapter 3: Detailed analysis of Nonerosive Reflux Disease Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nonerosive Reflux Disease Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nonerosive Reflux Disease Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of H2 Receptor Antagonists Table 3. Key Players of Antacids Table 4. Key Players of Proton pump inhibitors Table 3. Key Players of Others Table 4. Global Nonerosive Reflux Disease Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Pharmacies Table 6. Key Players of Online Pharmacies Table 7. Key Players of Retail Pharmacies Table 8. Global Nonerosive Reflux Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Nonerosive Reflux Disease Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Nonerosive Reflux Disease Treatment Market Share by Region (2021-2026) Table 11. Global Nonerosive Reflux Disease Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Nonerosive Reflux Disease Treatment Market Share by Region (2027-2032) Table 13. Nonerosive Reflux Disease Treatment Industry Trends Table 14. Nonerosive Reflux Disease Treatment Industry Drivers Table 15. Nonerosive Reflux Disease Treatment Industry Opportunities and Challenges Table 16. Nonerosive Reflux Disease Treatment Industry Restraints Table 17. Global Nonerosive Reflux Disease Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Nonerosive Reflux Disease Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Nonerosive Reflux Disease Treatment Key Company Head Office and Area Served Table 21. Global Nonerosive Reflux Disease Treatment Company, Product Type & Application Table 22. Global Nonerosive Reflux Disease Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Nonerosive Reflux Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Nonerosive Reflux Disease Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Nonerosive Reflux Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Nonerosive Reflux Disease Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Nonerosive Reflux Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Application (2027-2032) Table 35. Takeda Pharmaceutical Company Information Table 36. Takeda Pharmaceutical Business Overview Table 37. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Product Portfolio Table 39. Takeda Pharmaceutical Recent Development Table 40. Eisai Company Information Table 41. Eisai Business Overview Table 42. Eisai Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Eisai Nonerosive Reflux Disease Treatment Product Portfolio Table 44. Eisai Recent Development Table 45. Johnson & Johnson Company Information Table 46. Johnson & Johnson Business Overview Table 47. Johnson & Johnson Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Johnson & Johnson Nonerosive Reflux Disease Treatment Product Portfolio Table 49. Johnson & Johnson Recent Development Table 50. GlaxoSmithKline Company Information Table 51. GlaxoSmithKline Business Overview Table 52. GlaxoSmithKline Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. GlaxoSmithKline Nonerosive Reflux Disease Treatment Product Portfolio Table 54. GlaxoSmithKline Recent Development Table 55. AstraZeneca Company Information Table 56. AstraZeneca Business Overview Table 57. AstraZeneca Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. AstraZeneca Nonerosive Reflux Disease Treatment Product Portfolio Table 59. AstraZeneca Recent Development Table 60. SRS Pharmaceuticals Company Information Table 61. SRS Pharmaceuticals Business Overview Table 62. SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Product Portfolio Table 64. SRS Pharmaceuticals Recent Development Table 65. SFJ Pharmaceuticals Group Company Information Table 66. SFJ Pharmaceuticals Group Business Overview Table 67. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Product Portfolio Table 69. SFJ Pharmaceuticals Group Recent Development Table 70. Ironwood Pharmaceuticals Company Information Table 71. Ironwood Pharmaceuticals Business Overview Table 72. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Product Portfolio Table 74. Ironwood Pharmaceuticals Recent Development Table 75. Daewoong Pharmaceutical Company Information Table 76. Daewoong Pharmaceutical Business Overview Table 77. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Product Portfolio Table 79. Daewoong Pharmaceutical Recent Development Table 80. North America Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 81. North America Nonerosive Reflux Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 82. North America Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 83. North America Nonerosive Reflux Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 84. North America Nonerosive Reflux Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026) Table 86. North America Nonerosive Reflux Disease Treatment Market Size by Country (2027-2032) Table 87. Europe Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 88. Europe Nonerosive Reflux Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 89. Europe Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 90. Europe Nonerosive Reflux Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 91. Europe Nonerosive Reflux Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026) Table 93. Europe Nonerosive Reflux Disease Treatment Market Size by Country (2027-2032) Table 94. China Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 95. China Nonerosive Reflux Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 96. China Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 97. China Nonerosive Reflux Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 99. Asia Nonerosive Reflux Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 100. Asia Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 101. Asia Nonerosive Reflux Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Nonerosive Reflux Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026) Table 104. Asia Nonerosive Reflux Disease Treatment Market Size by Country (2027-2032) Table 105. South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 106. South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 107. South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 108. South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 109. South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026) Table 111. South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Nonerosive Reflux Disease Treatment Product Image Figure 2. Global Nonerosive Reflux Disease Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Nonerosive Reflux Disease Treatment Market Share by Type: 2025 VS 2032 Figure 4. H2 Receptor Antagonists Image Figure 5. Antacids Image Figure 6. Proton pump inhibitors Image Figure 7. Others Image Figure 8. Global Nonerosive Reflux Disease Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Nonerosive Reflux Disease Treatment Market Share by Application: 2025 VS 2032 Figure 10. Hospital Pharmacies Image Figure 11. Online Pharmacies Image Figure 12. Retail Pharmacies Image Figure 13. Global Nonerosive Reflux Disease Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 15. Global Nonerosive Reflux Disease Treatment Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Nonerosive Reflux Disease Treatment Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Nonerosive Reflux Disease Treatment Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Nonerosive Reflux Disease Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Nonerosive Reflux Disease Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 25. North America Nonerosive Reflux Disease Treatment Market Share by Type (2021-2032) Figure 26. North America Nonerosive Reflux Disease Treatment Market Share by Application (2021-2032) Figure 27. North America Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032) Figure 28. United States Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Canada Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Nonerosive Reflux Disease Treatment Market Share by Type (2021-2032) Figure 33. Europe Nonerosive Reflux Disease Treatment Market Share by Application (2021-2032) Figure 34. Europe Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032) Figure 35. Germany Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 36. France Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Italy Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Russia Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Nonerosive Reflux Disease Treatment Market Share by Type (2021-2032) Figure 43. China Nonerosive Reflux Disease Treatment Market Share by Application (2021-2032) Figure 44. Asia Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 45. Asia Nonerosive Reflux Disease Treatment Market Share by Type (2021-2032) Figure 46. Asia Nonerosive Reflux Disease Treatment Market Share by Application (2021-2032) Figure 47. Asia Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032) Figure 48. Japan Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 52. India Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Australia Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032) Figure 58. Brazil Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 63. UAE Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Chile Nonerosive Reflux Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • H2 Receptor Antagonists
  • Antacids
  • Proton pump inhibitors
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Takeda Pharmaceutical
  • Eisai
  • Johnson & Johnson
  • GlaxoSmithKline
  • AstraZeneca
  • SRS Pharmaceuticals
  • SFJ Pharmaceuticals Group
  • Ironwood Pharmaceuticals
  • Daewoong Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Nonerosive Reflux Disease Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 H2 Receptor Antagonists
  5. 1.2.3 Antacids
  6. 1.2.4 Proton pump inhibitors
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Nonerosive Reflux Disease Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital Pharmacies
  11. 1.3.3 Online Pharmacies
  12. 1.3.4 Retail Pharmacies
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Nonerosive Reflux Disease Treatment Growth Trends by Region
  15. 1.5.1 Global Nonerosive Reflux Disease Treatment Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Nonerosive Reflux Disease Treatment Market Size by Region (2021-2026)
  17. 1.5.3 Nonerosive Reflux Disease Treatment Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Nonerosive Reflux Disease Treatment Market Dynamics
  1. 2.1 Nonerosive Reflux Disease Treatment Industry Trends
  2. 2.2 Nonerosive Reflux Disease Treatment Industry Drivers
  3. 2.3 Nonerosive Reflux Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Nonerosive Reflux Disease Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Nonerosive Reflux Disease Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Nonerosive Reflux Disease Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Nonerosive Reflux Disease Treatment Key Company Head office and Area Served
  4. 3.4 Global Nonerosive Reflux Disease Treatment Company, Product Type & Application
  5. 3.5 Global Nonerosive Reflux Disease Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Nonerosive Reflux Disease Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Nonerosive Reflux Disease Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Nonerosive Reflux Disease Treatment Tier 1, Tier 2, and Tier 3
4 Nonerosive Reflux Disease Treatment Market by Type
  1. 4.1 Global Nonerosive Reflux Disease Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Nonerosive Reflux Disease Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Nonerosive Reflux Disease Treatment Market Size Share by Type (2021-2032)
5 Nonerosive Reflux Disease Treatment Market by Application
  1. 5.1 Global Nonerosive Reflux Disease Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Nonerosive Reflux Disease Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Nonerosive Reflux Disease Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical
  2. 6.1.1 Takeda Pharmaceutical Company Information
  3. 6.1.2 Takeda Pharmaceutical Business Overview
  4. 6.1.3 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eisai Nonerosive Reflux Disease Treatment Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Johnson & Johnson Nonerosive Reflux Disease Treatment Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GlaxoSmithKline Nonerosive Reflux Disease Treatment Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AstraZeneca Nonerosive Reflux Disease Treatment Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 SRS Pharmaceuticals
  32. 6.6.1 SRS Pharmaceuticals Company Information
  33. 6.6.2 SRS Pharmaceuticals Business Overview
  34. 6.6.3 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Product Portfolio
  36. 6.6.5 SRS Pharmaceuticals Recent Developments
  37. 6.7 SFJ Pharmaceuticals Group
  38. 6.7.1 SFJ Pharmaceuticals Group Company Information
  39. 6.7.2 SFJ Pharmaceuticals Group Business Overview
  40. 6.7.3 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Product Portfolio
  42. 6.7.5 SFJ Pharmaceuticals Group Recent Developments
  43. 6.8 Ironwood Pharmaceuticals
  44. 6.8.1 Ironwood Pharmaceuticals Company Information
  45. 6.8.2 Ironwood Pharmaceuticals Business Overview
  46. 6.8.3 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Product Portfolio
  48. 6.8.5 Ironwood Pharmaceuticals Recent Developments
  49. 6.9 Daewoong Pharmaceutical
  50. 6.9.1 Daewoong Pharmaceutical Company Information
  51. 6.9.2 Daewoong Pharmaceutical Business Overview
  52. 6.9.3 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Product Portfolio
  54. 6.9.5 Daewoong Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Nonerosive Reflux Disease Treatment Market Size (2021-2032)
  2. 7.2 North America Nonerosive Reflux Disease Treatment Market Size by Type
  3. 7.2.1 North America Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Nonerosive Reflux Disease Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Nonerosive Reflux Disease Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Nonerosive Reflux Disease Treatment Market Size by Application
  7. 7.3.1 North America Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Nonerosive Reflux Disease Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Nonerosive Reflux Disease Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Nonerosive Reflux Disease Treatment Market Size by Country
  11. 7.4.1 North America Nonerosive Reflux Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Nonerosive Reflux Disease Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Nonerosive Reflux Disease Treatment Market Size (2021-2032)
  2. 8.2 Europe Nonerosive Reflux Disease Treatment Market Size by Type
  3. 8.2.1 Europe Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Nonerosive Reflux Disease Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Nonerosive Reflux Disease Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Nonerosive Reflux Disease Treatment Market Size by Application
  7. 8.3.1 Europe Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Nonerosive Reflux Disease Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Nonerosive Reflux Disease Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Nonerosive Reflux Disease Treatment Market Size by Country
  11. 8.4.1 Europe Nonerosive Reflux Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Nonerosive Reflux Disease Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Nonerosive Reflux Disease Treatment Market Size (2021-2032)
  2. 9.2 China Nonerosive Reflux Disease Treatment Market Size by Type
  3. 9.2.1 China Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Nonerosive Reflux Disease Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Nonerosive Reflux Disease Treatment Market Share by Type (2021-2032)
  6. 9.3 China Nonerosive Reflux Disease Treatment Market Size by Application
  7. 9.3.1 China Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Nonerosive Reflux Disease Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Nonerosive Reflux Disease Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Nonerosive Reflux Disease Treatment Market Size (2021-2032)
  2. 10.2 Asia Nonerosive Reflux Disease Treatment Market Size by Type
  3. 10.2.1 Asia Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Nonerosive Reflux Disease Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Nonerosive Reflux Disease Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Nonerosive Reflux Disease Treatment Market Size by Application
  7. 10.3.1 Asia Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Nonerosive Reflux Disease Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Nonerosive Reflux Disease Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Nonerosive Reflux Disease Treatment Market Size by Country
  11. 10.4.1 Asia Nonerosive Reflux Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Nonerosive Reflux Disease Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst